Bio Green Med Solution (BGMS) Finished Goods (2010 - 2026)
Bio Green Med Solution (BGMS) posted quarterly Finished Goods of $709000.0 for Q1 2026, down 29.66% quarter-over-quarter from $1.0 million in Q4 2025.
Powered by 
Analysis
Bio Green Med Solution (BGMS) Finished Goods (2010 - 2026) Analysis & Trends
Bio Green Med Solution (BGMS) has reported Finished Goods for 5 consecutive years, with $709000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Finished Goods changed N/A year-over-year to $709000.0; the TTM figure through Mar 2026 stood at $709000.0 (changed N/A YoY), while the FY2025 annual figure was $1.0 million, changed N/A from the prior year.
- Finished Goods retreated to $709000.0 in Q1 2026 per BGMS's latest filing, from $1.0 million in the prior quarter.
- Across five years, Finished Goods topped out at $1.0 million in Q3 2025 and bottomed at $709000.0 in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.61 Bn | 133.76 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.50 Bn | 78.50 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.82 Bn | 59.64 Bn | 1.37 Bn |
| 4 | Moderna | 57.28 Bn | 52.14 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.45 Bn | 44.45 Bn | - |
| 6 | BeOne Medicines | 40.32 Bn | 35.22 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.39 Bn | 32.08 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.12 Bn | 27.29 Bn | - |
| 9 | Insmed | 27.35 Bn | 26.19 Bn | 358.27 Mn |
| 10 | Bio Green Med Solution | 4.95 Mn | 1.16 Mn | 79,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 734,000.00 |
| Mar 31, 2026 | 709,000.00 |
| Dec 31, 2025 | 1.01 Mn |
| Sep 30, 2025 | 1.05 Mn |
| Jun 30, 2012 | 50,000.00 |
| Mar 31, 2012 | 109,000.00 |
| Dec 31, 2011 | 182,000.00 |
| Sep 30, 2011 | 165,000.00 |
| Jun 30, 2011 | 147,000.00 |
| Dec 31, 2010 | 174,000.00 |